| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/12/2007 | US20070160630 Hepatitis-c virus 4, 5 and 6 |
| 07/12/2007 | US20070160624 Peptides of the Bacillus anthracis Anthrax Toxin Lethal factor Protein pX01-107; methods of stimulating immune response; antisense agents; vaccine |
| 07/12/2007 | US20070160618 Cardiotrophin-1 compositions and methods for the treatment of tumor |
| 07/12/2007 | US20070160617 PSMA antibody-drug conjugates |
| 07/12/2007 | US20070160616 Methods of treating Alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof |
| 07/12/2007 | US20070160614 Human TIMP-1 antibodies |
| 07/12/2007 | US20070160613 Monoclonal antibodies to hepatocyte growth factor |
| 07/12/2007 | US20070160612 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 07/12/2007 | US20070160609 Interferon antagonists useful for the treatment of interferon related diseases |
| 07/12/2007 | US20070160608 Treatment with anti-vegf antibodies |
| 07/12/2007 | US20070160607 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 07/12/2007 | US20070160605 Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody |
| 07/12/2007 | US20070160604 Methods of identifying compounds capable of modulating t cell immune responses involving sema4a protein |
| 07/12/2007 | US20070160603 Antibodies Against Tumor Necrosis Factor Delta (APRIL) |
| 07/12/2007 | US20070160602 Compositions and methods of using galectin-8 as an inhibitor of tumor cell growth |
| 07/12/2007 | US20070160601 Neutralizing antibodies against primate psgl-1 and uses therefor |
| 07/12/2007 | US20070160600 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
| 07/12/2007 | US20070160598 Binding polypeptides with diversified and consensus vh/vl hypervariable sequences |
| 07/12/2007 | US20070160597 Optimized Fc variants and methods for their generation |
| 07/12/2007 | US20070160596 For use as suppressors of cancer, cell or tissue proliferation and of inflammatory disorders |
| 07/12/2007 | US20070160595 Human Tumor Necrosis Factor TR20 and Methods Based Thereon |
| 07/12/2007 | US20070160594 Method of Diagnosing and Treating Cartilaginous Disorders |
| 07/12/2007 | US20070160585 Remedy for prion disease and method of producing the same |
| 07/12/2007 | US20070160579 Methods of modulating a mammalian cytokine |
| 07/12/2007 | US20070160576 IL-17A/F heterologous polypeptides and therapeutic uses thereof |
| 07/12/2007 | US20070160574 Design of CXC chemokine analogs for the treatment of human diseases |
| 07/12/2007 | US20070160572 Colloidal metal compositions and methods |
| 07/12/2007 | US20070160570 Chimeric polypeptides containing chemokine domains |
| 07/12/2007 | US20070160558 Peptide composition |
| 07/12/2007 | US20070160534 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands |
| 07/12/2007 | US20070160531 Targeting endothelium for tissue-specific delivery of agents |
| 07/12/2007 | US20070160530 Antibodies and molecules derived therefrom that bind to steap-1 proteins |
| 07/12/2007 | US20070160529 Radioimmunoconjugates for targeted alpha therapy |
| 07/12/2007 | CA2674269A1 Three component carbohydrate vaccine |
| 07/12/2007 | CA2636265A1 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (nait) |
| 07/12/2007 | CA2635849A1 An antibody against periosin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periosin is involved |
| 07/12/2007 | CA2635623A1 Anti-cd19 antibodies with reduced immunogenicity |
| 07/12/2007 | CA2635615A1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130 |
| 07/12/2007 | CA2635560A1 Chicken virus vaccine and diagnostic |
| 07/12/2007 | CA2634997A1 Immunoglobulin g (igg) concentrate depleted of anti-a and anti-b antibodies and of polyreactive iggs |
| 07/12/2007 | CA2634989A1 Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them |
| 07/12/2007 | CA2633222A1 Antibodies directed to her-3 and uses thereof |
| 07/11/2007 | EP1806403A2 Human cancer antigen NY ESO 1/CAG-3 and gene encoding same |
| 07/11/2007 | EP1806402A2 CTLA4/CD28 ligands and uses therefor |
| 07/11/2007 | EP1806399A2 Nucleic acid molecules encoding a branching enzyme comprising bacteria of the genus Neisseria and method for producing alpha-1.6-branched alpha-1, 4-glucanes |
| 07/11/2007 | EP1806365A1 Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them |
| 07/11/2007 | EP1806364A2 New anti-IGF-IR antibodies and their applications |
| 07/11/2007 | EP1806363A1 METHOD OF DETECTING HEPATITIS B VIRUS s ANTIGEN |
| 07/11/2007 | EP1806362A2 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 07/11/2007 | EP1806357A1 Hypoxia inducible factor-1 and method of use |
| 07/11/2007 | EP1806146A1 Agonists or antagonists of cutaneous T cell-attracting chemokine (CTACK) or vasoactive intestinal contractor (VIC) chemokines |
| 07/11/2007 | EP1806145A1 Remedy for inflammatory diseases |
| 07/11/2007 | EP1806143A2 Baff receptor (BCMA), an immunoregulatory agent |
| 07/11/2007 | EP1806142A1 Method for the production of (poly)peptides by using truncated variants of the SV 40 large T antigen with an intact N terminus |
| 07/11/2007 | EP1805519A2 Wnt proteins and detection and treatment of cancer |
| 07/11/2007 | EP1805515A2 Immunoassays for lamotrigine |
| 07/11/2007 | EP1805514A2 Immunoassays for topiramate |
| 07/11/2007 | EP1805320A2 Methods for refolding of recombinant antibodies |
| 07/11/2007 | EP1805309A2 C1q related protein |
| 07/11/2007 | EP1805222A1 Antibodies directed to the mammalian eag1 ion channel protein |
| 07/11/2007 | EP1805221A1 Monoclonal antibody against frizzled receptors |
| 07/11/2007 | EP1805220A1 Method for treating tumors using anti-osteopontin antibodies |
| 07/11/2007 | EP1805219A1 Angiopoietin-2 specific binding agents |
| 07/11/2007 | EP1805215A2 Chemically modified peptide analogs |
| 07/11/2007 | EP1805214A2 T-cell stimulatory peptides from the melanoma-associated chondroitin sulfate proteoglycan and their use |
| 07/11/2007 | EP1805205A1 Methods for refolding polypeptides |
| 07/11/2007 | EP1804829A1 T-cadherin antigen arrays and uses thereof |
| 07/11/2007 | EP1678308A4 Expression vector for secreting antibody fragment using e. coli signal sequence and method for mass-producing antibody fragment |
| 07/11/2007 | EP1553832B1 Cell separation compositions and methods |
| 07/11/2007 | EP1506408A4 Methods for diagnosing htlv-i-mediated diseases |
| 07/11/2007 | EP1412471A4 Apparatus and method for determining the onset and presence of sepsis conditions |
| 07/11/2007 | EP1395829B1 Cancer associated protein |
| 07/11/2007 | EP1218504B1 Gl50 molecules and uses therefor |
| 07/11/2007 | EP1146889B1 IDENTIFICATION OF SPECIFIC DIFFERENTIALLY EXPRESSED MYCOBACTERIAL ANTIGENS AND MEDICAL USE OF THE MYCOBACTERIAL PROTEINS Rv0068 AND Rv3407 |
| 07/11/2007 | EP1141283B1 NOVEL METHOD FOrR IDENTIFICATION OF A COMPOUND MODULATING INTERACTION BETWEEN A TNF LIGAND AND ITS RECEPTOR ON B CELLS |
| 07/11/2007 | EP0979246B1 Human monoclonal antibodies to epidermal growth factor receptor |
| 07/11/2007 | EP0808367B1 Mucosal vascular addressins and uses thereof |
| 07/11/2007 | EP0577752B2 Human pf4a receptors and their use |
| 07/11/2007 | CN1997897A Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators |
| 07/11/2007 | CN1997893A Assay for antibodies |
| 07/11/2007 | CN1997756A Haplotype markers and methods of using the same to determine response to treatment |
| 07/11/2007 | CN1997751A Antibodies and related molecules that bind to PSCA proteins |
| 07/11/2007 | CN1997741A Novel mite allergen |
| 07/11/2007 | CN1997670A Human anti-KIR antibodies |
| 07/11/2007 | CN1997669A Monoclonal antibodies to gastrin hormone |
| 07/11/2007 | CN1997668A Immunoglobulins |
| 07/11/2007 | CN1997667A Humanized FcgammaRIIB-specific antibodies and methods of use thereof |
| 07/11/2007 | CN1997663A Polypeptides from non-typeable haemophilus influenzae |
| 07/11/2007 | CN1997398A Passive targeting of cytotoxic agents |
| 07/11/2007 | CN1997397A Calicheamicin conjugates |
| 07/11/2007 | CN1997394A Compositions and methods comprising an EGFL7 antagonist for modulating vascular development |
| 07/11/2007 | CN1997382A Bispecific binding agents for modulating biological activity |
| 07/11/2007 | CN1325517C Anti hepatitis C virus antibody and uses thereof |
| 07/11/2007 | CN1325516C Biomimetic affinity purification method of vitellus immune globulin |
| 07/11/2007 | CN1325513C Oil bodies and associated proteins as affinity matrices |
| 07/11/2007 | CN1325115C Methods for CTL and T helper cell in therapeutic vaccination |
| 07/10/2007 | US7241881 Genes encoding insect odorant receptors and uses thereof |
| 07/10/2007 | US7241880 T1R taste receptors and genes encoding same |
| 07/10/2007 | US7241877 Humanised antibodies |
| 07/10/2007 | US7241873 Recombinant anti-osteopontin antibody and use thereof |